May 11, 2026 11:31AM
May 11, 2026 05:18AM
May 4, 2026 04:05PM
Apr 27, 2026 08:44AM
Apr 27, 2026 08:44AM
Mar 9, 2026 02:38PM
Mar 3, 2026 06:12AM BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $105 at Barclays
Feb 26, 2026 08:23AM
Feb 23, 2026 04:05PM
Feb 12, 2026 04:05PM
Feb 12, 2026 04:05PM
Jan 29, 2026 04:05PM
Jan 29, 2026 04:05PM
Jan 26, 2026 07:45AM BioMarin plans $850 million bond offering to fund Amicus acquisition
Jan 26, 2026 07:45AM
Jan 20, 2026 01:08AM
Dec 22, 2025 09:32AM
Dec 22, 2025 07:09AM
Dec 19, 2025 07:45AM
Dec 19, 2025 07:45AM
Dec 3, 2025 06:40AM Leerink Partners Downgrades BioMarin Pharmaceutical Inc. (BMRN) to Market Perform
Oct 28, 2025 09:23AM
Oct 27, 2025 04:03PM
Aug 19, 2025 07:08AM
Aug 5, 2025 06:46AM
Aug 4, 2025 04:02PM
Jul 1, 2025 08:46AM
Jul 1, 2025 08:45AM BioMarin Announces Completion of Acquisition of Inozyme
May 27, 2025 09:44AM
May 19, 2025 09:54AM
May 16, 2025 01:11PM
May 16, 2025 12:22PM
May 16, 2025 07:31AM
May 16, 2025 07:30AM
Mar 15, 2025 04:00PM Bernstein provides 2025 M&A outlook for U.S. Biotech and Pharma
Feb 24, 2025 04:05PM
Feb 24, 2025 04:05PM
Sep 6, 2024 08:19AM
Feb 27, 2024 09:00AM
Dec 20, 2023 04:06PM
Dec 20, 2023 04:05PM
Jun 29, 2023 02:36PM BioMarin Pharma (BMRN) Announces FDA Approves ROCTAVIAN, the First and Only Gene Therapy for Adults with Severe Hemophilia A
Jun 29, 2023 02:34PM
Jan 10, 2022 09:26AM
Dec 15, 2021 04:06PM
Dec 15, 2021 04:05PM
Dec 15, 2020 11:57AM
Aug 19, 2020 09:26AM
Dec 16, 2019 05:40PM Roche to complete $4.3 billion Spark deal as regulators give all clear
Dec 16, 2019 09:23AM

1,158,425 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All